title: Temporary methods of family planning listed as provided by facilities, percentage available on day of survey visit and percentage not available
linearized_input: Temporary methods of family planning listed as provided by facilities, percentage available on day of survey visit and percentage not available | (Method provided and available, Combined oral contraceptive pills, 87) (Method provided, not available, Combined oral contraceptive pills, 13) (Method provided and available, Progestin-only oral pill, 74) (Method provided, not available, Progestin-only oral pill, 26) (Method provided and available, Progestin-only injectable, 91) (Method provided, not available, Progestin-only injectable, 9) (Method provided and available, Combined injectable, 72) (Method provided, not available, Combined injectable, 28) (Method provided and available, Male condom, 89) (Method provided, not available, Male condom, 11) (Method provided and available, Female condom, 78) (Method provided, not available, Female condom, 22) (Method provided and available, Intrauterine contraceptive device, 84) (Method provided, not available, Intrauterine contraceptive device, 16) (Method provided and available, Implant, 91) (Method provided, not available, Implant, 9) (Method provided and available, Cyclebeads for SDM, 48) (Method provided, not available, Cyclebeads for SDM, 52) (Method provided and available, All methods provided, 60) (Method provided, not available, All methods provided, 40) (Method provided and available, Emergency contraceptive pill, 76) (Method provided, not available, Emergency contraceptive pill, 24)
table_text: Among facilities that reported providing 3-month progestin-only injectables, 91 percent had the method on the day of the assessment (9 percent did not). Similarly, 87 percent of facilities that provide combined oral contraceptives had the pills in stock (13 percent did not). An impressive 89 percent of facilities that provide male condoms had them available on the day of the assessment (11 percent did not). The gap is most evident for CycleBeads (Standard Day Method); less than half of facilities (48 percent) that reported providing CycleBeads had the beads in stock.
target: Among facilities that reported providing 3-month progestin-only injectables, 91 percent had the method on the day of the assessment (9 percent did not).